India  

Remdesivir becomes first COVID-19 drug put forward for use in the EU

Video Credit: euronews (in English) - Duration: 00:35s - Published
Remdesivir becomes first COVID-19 drug put forward for use in the EU

Remdesivir becomes first COVID-19 drug put forward for use in the EU

The anti-viral drug is the first to be recommended for authorisation in the EU.

View on euronews

0
shares
ShareTweetSavePostSend
 

💡 newsR Knowledge: Other News Mentions

Remdesivir Remdesivir Antiviral drug

FDA Warns Against Combining Remdesivir And Hydroxychloroquine [Video]

FDA Warns Against Combining Remdesivir And Hydroxychloroquine

The FDA has issued a warning to healthcare providers regarding two medications being tested with COVID-19. The warning cautions against administering hydroxychloroquine in combination with remdesivir. According to Reuters, the agency said the co-administration may result in the reduced effectiveness of remdesivir. Remdesivir is currently the only medication to show benefits against COVID-19 in clinical trials.

Credit: Wochit News    Duration: 00:31Published
Coronavirus cases in India reach 2.86 lakh, ICMR says no 'community transmission' [Video]

Coronavirus cases in India reach 2.86 lakh, ICMR says no 'community transmission'

Coronavirus cases in India have crossed over 2.8 lakh. The country witnessed the highest single-day spike of 9,996 more cases in last 24 hours. In a single day, as many as 357 deaths were reported making the total toll to 8102. Out of the total number of cases, 1,37,448 are active while 1,41,029 have been cured. In Maharashtra, coronavirus cases reached 94,041 including 46,086 active cases and 3,438 deaths which are highest in the country. Indian Council of Medical Research informed that there is no 'community transmission' of COVID-19 in India. Earlier on June 11, Lav Agarwal, Joint Secretary, Health Ministry, said that India's recovery rate is 49.21 per cent. A total of 52,13,140 samples have been tested in the country, including 1,51,808 in the last 24 hours, according to ICMR. One new case of COVID-19 reported in ITBP in the last 24 hours. Remdesivir, an antiviral drug and Tocilizumab, an immunomodulator, are being considered by the Union Health Ministry for 'restricted, emergency use' and on 'compassionate grounds' to treat severely ill COVID-19 patients.

Credit: ANI    Duration: 01:51Published
Matt Hancock: New drug trial probably biggest step forward in Covid-19 treatment [Video]

Matt Hancock: New drug trial probably biggest step forward in Covid-19 treatment

Health Secretary Matt Hancock announced plans for a new trial of drug Remdesivir, a treatment originally developed to fight Ebola, which appears to shorten recovery time for people with Covid-19.

Credit: PA - Press Association STUDIO    Duration: 00:43Published

European Union European Union Economic and political union of European states

New Payment System Will Challenge Mastercard And Visa [Video]

New Payment System Will Challenge Mastercard And Visa

As many as 20 major EU banks are set to announce details for a new payments initiative in the very near future. This announcement came from Electronic Payments International. Business Insider reports the system is referred to as the Pan European Payment System Initiative (PEPSI). It will process card payments in addition to making fund transfers and mobile payments without using Mastercard's or Visa's network.

Credit: Wochit News    Duration: 00:30Published
Brexit briefing: 178 days until the end of the transition period [Video]

Brexit briefing: 178 days until the end of the transition period

The UK left the European Union on January 31. Here we look at the latest figures and key dates in the ongoing Brexit process. Quote from Sarah Hewin, Chief economist at Standard Chartered, speaking to the Financial Times.

Credit: PA - Press Association STUDIO    Duration: 00:48Published
Brexit briefing: 179 days until the end of the transition period [Video]

Brexit briefing: 179 days until the end of the transition period

The UK left the European Union on January 31. Here we look at the latest figures and key dates in the ongoing Brexit process.

Credit: PA - Press Association STUDIO    Duration: 00:50Published

You Might Like

Related news from verified sources

India approves emergency use of remdesivir to treat Covid-19 patients

Remdesivir is the first drug to show improvement in Covid-19 patients in formal clinical trials. It...
IndiaTimes - Published

South Korea backs remdesivir for Covid-19, urges caution with dexamethasone

South Korea has added Gilead's anti-viral drug remdesivir to its coronavirus treatment guidelines in...
IndiaTimes - Published


Tweets about this


Related videos from verified sources

Gilead's remdesivir gets conditional EU clearance [Video]

Gilead's remdesivir gets conditional EU clearance

The European Commission said Friday it had given conditional approval for the use of antiviral drug remdesivir in severe COVID-19 patients. As Fred Katayama reports, that makes it the region's first..

Credit: Reuters Studio     Duration: 00:59Published
Sensex closes 180 points up, Glenmark Pharma jumps 27 pc [Video]

Sensex closes 180 points up, Glenmark Pharma jumps 27 pc

Equity benchmark indices wiped out early gains but closed over half a per cent higher on Monday led by gains in banking, pharma and metal stocks. The rising tension between India and China besides a..

Credit: ANI     Duration: 01:15Published
Trump Criticizes FDA Over Hydroxychloroquine Decision [Video]

Trump Criticizes FDA Over Hydroxychloroquine Decision

The U.S. FDA has revoked the emergency use authorization for hydroxychloroquine to treat COVID-19. According to Reuters, following the revocation, the FDA quickly came under fire from President Donald..

Credit: Wochit     Duration: 00:32Published